Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Fins on sedar

<< Previous

Bullboard Posts

Next >>

Comment by bealerton Feb 28, 2024 8:25pm

89 Views

Post# 35905304

RE:Fins on sedar

If you had to choose the incompetence level between HowHee and Hoppy, which one would you choose?

They don't even have the ballz to properly report revenue and still want our confidence.

What a joke.

Absolutely disgusting.

If and when this turns around, it will be very, very difficult to retract how we feel about those two fearless leaders.

BeAlert

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario